C G Moertel. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenocarcinoma/drug therapyAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useAntineoplastic Agents/toxicityBone Marrow Diseases/chemically inducedCarmustine/adverse effectsCarmustine/therapeutic useCarmustine/toxicityColonic Neoplasms/drug therapyCyclohexanes/adverse effectsCyclohexanes/therapeutic useCyclohexanes/toxicityDrug EvaluationDrug Therapy, CombinationFluorouracil/therapeutic useGastrointestinal Neoplasms/drug therapyHematologic Diseases/chemically inducedHumansKidney Diseases/chemically inducedLeukocyte CountNeoplasm MetastasisNitrosourea Compounds/adverse effectsNitrosourea Compounds/therapeutic useNitrosourea Compounds/toxicityRectal Neoplasms/drug therapyTime Factors
Substances: See more » Antineoplastic AgentsCyclohexanesNitrosourea CompoundsFluorouracilCarmustine
Year: 1973 PMID: 4748872
Source DB: PubMed Journal: Cancer Chemother Rep 3 ISSN: 0069-0139